[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$54share](/topic/$54share) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Key moves from todays filings: -Spin-off: $JNJ to separate its Orthopaedics business into standalone DePuy Synthes within 18-24 months -Merger Arb: $RYN/$PCH agree to $8.2B all-stock merger XXXXXX Rayonier shares per PCH share (8.25% premium) -Merger Arb: $AKRO to be acquired by Novo Nordisk for $54/share plus $6/share CVR (total $5.2B) -Allegation: $JEF addressed fraud allegations related to Point Bonita Capitals exposure in First Brands Group -CEO Change: $VMC names Ronnie A. Pruitt next CEO; $PRIM appoints Koti Vadlamudi as CEO Full details in thread below" [X Link](https://x.com/catalyst8kio/status/1978390416111345805) [@catalyst8kio](/creator/x/catalyst8kio) 2025-10-15T09:20Z XX followers, XX engagements "$ETNB competitor developing a MASH treatment $AKRO was just acquired by $NVO. Big pharma is clearly betting heavily on these drugs. Theres also an interesting CVR component attached to the AKRO deal. The offer is for $54/share in cash + $6/share in CVR and the stock currently trades at $54.08/share. The CVR payout is tied to the cirrhosis indication approval as well but with much stronger upside than in the case of ETNB. I havent looked into this in detail yet but its worth checking out" [X Link](https://x.com/InvestSpecial/status/1976643630484869147) [@InvestSpecial](/creator/x/InvestSpecial) 2025-10-10T13:39Z 31K followers, 5818 engagements "Akero Therapeutics $AKRO +19% surges on $5.2B Novo Nordisk acquisition deal $54/share cash plus $X if MASH drug approved. Closes by year-end. @jonnajarian @petenajarian #ITSNOTANOPTION 📙" [X Link](https://x.com/MarketRebels/status/1976350699479879730) [@MarketRebels](/creator/x/MarketRebels) 2025-10-09T18:15Z 354.3K followers, 6525 engagements "📣 Biotech Stock News 10/09 @ Open $TELO XX% Discovery of Telomir-1 in Cancer Cells $AKRO XX% Acquisition for up to $XXX Billion $NGNE XX% Positive Regulatory Update for NGN-401 $CDTX XX% FDA Breakthrough Therapy Designation for CD388 $APGE X% Pricing of $XXX Million Offering $SXTP X% Unveils Chronic Babesiosis Clinical Trial $ANVS X% Novel Biomarker Data in Alzheimer's $WGS X% Launch of Autism Partnership Program $PTHS X% Launches Moms Against Molluscum Movement $ADIL X% Partners for Precision Medicine Testing $CPRX X% Presentations at Upcoming Scientific Conferences $AMIX X% U.S. Patent for" [X Link](https://x.com/BiopharmIQ/status/1976314440908931409) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T15:50Z 27.4K followers, 9824 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Key moves from todays filings: -Spin-off: $JNJ to separate its Orthopaedics business into standalone DePuy Synthes within 18-24 months -Merger Arb: $RYN/$PCH agree to $8.2B all-stock merger XXXXXX Rayonier shares per PCH share (8.25% premium) -Merger Arb: $AKRO to be acquired by Novo Nordisk for $54/share plus $6/share CVR (total $5.2B) -Allegation: $JEF addressed fraud allegations related to Point Bonita Capitals exposure in First Brands Group -CEO Change: $VMC names Ronnie A. Pruitt next CEO; $PRIM appoints Koti Vadlamudi as CEO Full details in thread below"
X Link @catalyst8kio 2025-10-15T09:20Z XX followers, XX engagements
"$ETNB competitor developing a MASH treatment $AKRO was just acquired by $NVO. Big pharma is clearly betting heavily on these drugs. Theres also an interesting CVR component attached to the AKRO deal. The offer is for $54/share in cash + $6/share in CVR and the stock currently trades at $54.08/share. The CVR payout is tied to the cirrhosis indication approval as well but with much stronger upside than in the case of ETNB. I havent looked into this in detail yet but its worth checking out"
X Link @InvestSpecial 2025-10-10T13:39Z 31K followers, 5818 engagements
"Akero Therapeutics $AKRO +19% surges on $5.2B Novo Nordisk acquisition deal $54/share cash plus $X if MASH drug approved. Closes by year-end. @jonnajarian @petenajarian #ITSNOTANOPTION 📙"
X Link @MarketRebels 2025-10-09T18:15Z 354.3K followers, 6525 engagements
"📣 Biotech Stock News 10/09 @ Open $TELO XX% Discovery of Telomir-1 in Cancer Cells $AKRO XX% Acquisition for up to $XXX Billion $NGNE XX% Positive Regulatory Update for NGN-401 $CDTX XX% FDA Breakthrough Therapy Designation for CD388 $APGE X% Pricing of $XXX Million Offering $SXTP X% Unveils Chronic Babesiosis Clinical Trial $ANVS X% Novel Biomarker Data in Alzheimer's $WGS X% Launch of Autism Partnership Program $PTHS X% Launches Moms Against Molluscum Movement $ADIL X% Partners for Precision Medicine Testing $CPRX X% Presentations at Upcoming Scientific Conferences $AMIX X% U.S. Patent for"
X Link @BiopharmIQ 2025-10-09T15:50Z 27.4K followers, 9824 engagements
/topic/$54share/posts